Publications by authors named "A Varshavsky"

Article Synopsis
  • Aggressive end-of-life (EOL) care for cancer patients often results in more hospitalizations and a poorer quality of death, while effective goals of care (GOC) discussions can lead to fewer hospitalizations and increased hospice use.* -
  • A study at an academic cancer center found that less than half of patients had documented GOC discussions, despite those discussions being linked to higher rates of hospice enrollment and lower hospitalizations.* -
  • It’s suggested that hematology-oncology fellowship programs should enhance communication skills training to improve the quality of GOC documentation and EOL care for patients.*
View Article and Find Full Text PDF
N-degron pathways.

Proc Natl Acad Sci U S A

September 2024

An N-degron is a degradation signal whose main determinant is a "destabilizing" N-terminal residue of a protein. Specific N-degrons, discovered in 1986, were the first identified degradation signals in short-lived intracellular proteins. These N-degrons are recognized by a ubiquitin-dependent proteolytic system called the Arg/N-degron pathway.

View Article and Find Full Text PDF

Despite advances in treatments over the last decades, a uniformly reliable and free of side effects therapy of human cancers remains to be achieved. During chromosome replication, a premature halt of two converging DNA replication forks would cause incomplete replication and a cytotoxic chromosome nondisjunction during mitosis. In contrast to normal cells, most cancer cells bear numerous DNA deletions.

View Article and Find Full Text PDF

Acute myeloid leukemia (AML) is an aggressive malignancy that requires rapid treatment with chemotherapies to reduce tumor burden. However, these chemotherapies can compromise lymphocyte function, thereby hindering normal anti-tumor immune responses and likely limiting the efficacy of subsequent immunotherapy. To better understand these negative impacts, we assessed the immunological effects of standard-of-care AML therapies on lymphocyte phenotype and function over time.

View Article and Find Full Text PDF

N-degron pathways are proteolytic systems that target proteins bearing N-terminal (Nt) degradation signals (degrons) called N-degrons. Nt-Arg of a protein is among Nt-residues that can be recognized as destabilizing ones by the Arg/N-degron pathway. A proteolytic cleavage of a protein can generate Arg at the N terminus of a resulting C-terminal (Ct) fragment either directly or after Nt-arginylation of that Ct-fragment by the Ate1 arginyl-tRNA-protein transferase (R-transferase), which uses Arg-tRNA as a cosubstrate.

View Article and Find Full Text PDF